Epigenetics Market Poised for Robust 18% CAGR Growth Driven by R&D and Therapeutics Demand
The epigenetics market in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 18.3% from 2023 to 2028.